Results of Dasatinib Therapy in Patients With Early Chronic-Phase Chronic Myeloid Leukemia

PURPOSE: Dasatinib is effective therapy for chronic myeloid leukemia (CML) after imatinib failure. In this study, we investigate the efficacy of dasatinib as initial therapy for patients with CML in early chronic phase. PATIENTS AND METHODS: Patients with newly diagnosed CML in early chronic phase w...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Cortes, Jorge E., Jones, Dan, O'Brien, Susan, Jabbour, Elias, Ravandi, Farhad, Koller, Charles, Borthakur, Gautam, Walker, Brenda, Zhao, Weiqiang, Shan, Jianqin, Kantarjian, Hagop
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Clinical Oncology 2010
Témata:
Original Reports
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2815702/
https://ncbi.nlm.nih.gov/pubmed/20008620
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.25.4920
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky